About Contact Us Careers
Sign In

Digital Biomarker Market Trends

  • Report ID: 3217
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Global Digital Biomarker Market TOC

  1. An Outline of the Global Digital Biomarker Market
    1. Market Definition
    2. Market Segmentation
    3. Industry Overview
  2. Assumptions & Abbreviations
  3. Research Methodology & Approach
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. Service Providers 
      3. End Users
    3. Secondary Research
    4. Market Size Estimation
  4. Summary of the Report for Key Decision Makers
  5. Forces of Market Constituents
    1. Factors/drivers impacting the growth of the market
    2. Market trends for better business practices
  6. Key Market Opportunities for Business Growth
  7. Major Roadblocks for the Market Growth
  8. Decarbonization Strategy and Carbon Credit Benefits for Market Players
    1. Global Government Decarbonization Plans/Goals by Each Country under 2015 Agreement Agreed by 200 Countries
    2. Measures taken by Countries to Reduce Carbon Footprints
    3. Carbon Credits and Subsidy Plans/Benefits Rolled out by the Government for Market Players
    4. Effective Ways to Harness Carbon-Credits and Impact on Profit Margins
    5. Demand Impact on the Companies Opting for Carbon Credits
  9. Government Regulation: How They Would aid Business?
  10. Industry Risk Analysis
  11. Global Economic Outlook: Challenges for Global Recovery and its Impact on Global Digital Biomarker Market
    1. Ukraine-Russia crisis
    2. Potential US economic slowdown
  12. Pipeline Analysis
  13. Industry Growth Outlook
  14. Industry Value Chain Analysis
  15. End User Analysis
  16. Competitive Positioning: Strategies to Differentiate a Company From its Competitor
  17. Competitive Model: A Detailed Inside View for Investors
    1. Company Market Share (2023)
    2. Business Profile of Key Enterprise
    3. nQ Medical
      1. ALTOIDA
      2. ActiGraph, LLC
      3. VivoSense
      4. EVOCAL Health GmbH
      5. Koneksa
      6. Cosinuss GmbH
      7. Biofourmis
      8. Lunit Inc.
      9. IMVARIA Inc.
  18. Global Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
        3. Wearables, Market Value (USD Million) and CAGR, 2023-2036F
        4. Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
        6. Others, Market Value (USD Million) and CAGR, 2023-2036F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
      2. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          4. Others, Market Value (USD Million) and CAGR, 2023-2036F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        6. Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
      3. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2023-2036F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
      4. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
        3. Others, Market Value (USD Million) and CAGR, 2023-2036F
      5. Global Digital Biomarker Market Segmentation Analysis (2023-2036) By Geography
        1. North America, Market Value (USD Million) and CAGR, 2023-2036F
        2. Europe, Market Value (USD Million) and CAGR, 2023-2036F
        3. Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
        4. Latin America, Market Value (USD Million) and CAGR, 2023-2036F
        5. Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F
  19. Cross Analysis of Components w.r.t. Application (USD Million), 2023
  20. North America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
        3. Wearables, Market Value (USD Million) and CAGR, 2023-2036F
        4. Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
        6. Others, Market Value (USD Million) and CAGR, 2023-2036F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
      2. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          4. Others, Market Value (USD Million) and CAGR, 2023-2036F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        6. Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
      3. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2023-2036F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
      4. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
        3. Others, Market Value (USD Million) and CAGR, 2023-2036F
    4. North America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
      1. US, Market Value (USD Million) and CAGR, 2023-2036F
      2. Canada, Market Value (USD Million) and CAGR, 2023-2036F
  21. Europe Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Europe Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. UK, Market Value (USD Million) and CAGR, 2023-2036F
        2. Germany, Market Value (USD Million) and CAGR, 2023-2036F
        3. France, Market Value (USD Million) and CAGR, 2023-2036F
        4. Italy, Market Value (USD Million) and CAGR, 2023-2036F
        5. Spain, Market Value (USD Million) and CAGR, 2023-2036F
        6. Russia, Market Value (USD Million) and CAGR, 2023-2036F
        7. Netherlands, Market Value (USD Million) and CAGR, 2023-2036F
        8. Rest of Europe, Market Value (USD Million) and CAGR, 2023-2036F
  22. Asia Pacific Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Asia Pacific Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. China, Market Value (USD Million) and CAGR, 2023-2036F
        2. Japan, Market Value (USD Million) and CAGR, 2023-2036F
        3. India, Market Value (USD Million) and CAGR, 2023-2036F
        4. Australia, Market Value (USD Million) and CAGR, 2023-2036F
        5. South Korea, Market Value (USD Million) and CAGR, 2023-2036F
        6. Singapore, Market Value (USD Million) and CAGR, 2023-2036F
        7. Rest of Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
  23. Latin America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Latin America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. Mexico, Market Value (USD Million) and CAGR, 2023-2036F
        2. Argentina, Market Value (USD Million) and CAGR, 2023-2036F
        3. Brazil, Market Value (USD Million) and CAGR, 2023-2036F
        4. Rest of Latin America, Market Value (USD Million) and CAGR, 2023-2036F
  24. Middle East & Africa Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Middle East & Africa Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. GCC, Market Value (USD Million) and CAGR, 2023-2036F
        2. Israel, Market Value (USD Million) and CAGR, 2023-2036F
        3. South Africa, Market Value (USD Million) and CAGR, 2023-2036F
        4. Rest of Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F

Digital Biomarker Market Trends

Growth Drivers

  • Remote Sensing Technologies are Getting More Popular – These technological devices also enable professionals to find patients and retrieve their medical records more rapidly. Remote sensing and monitoring technologies allow healthcare providers to obtain timely information about a patient's vital signs without needing to schedule an in-person visit.
  • Growing Use of Biomarkers for Identifying Neurological Disorder– The number of deaths from neurological illnesses has grown by 39% since 1990.  The growing environmental and life pressure has increased the frequency of neurological disorders, such as Alzheimer's disease, dementia, and others. Moreover, healthcare providers and the government are taking initiative to address the problem. Alzheimer's Disease Biomarkers Summit is a digital forum dedicated to addressing the issue of establishing clinically proven markers for early identification and Alzheimer's treatment.
  • Rising Development of Drug Delivery Method– AstraZeneca is working to develop new modalities for drug delivery systems to target and control the release of molecules directly into the tissues and cells. Biomarkers enable to increase in the extent of the new drug to reach the desired target.

Challenges

  • Standards for Interoperability of Digital Biomarkers are Lacking- Healthcare systems in nations with a low income face intrinsic limitations in addressing seamless connectivity, offering substantial obstacles for healthcare interoperability. Furthermore, the majority of healthcare systems in those locations lack the necessary data insights as well as integration technologies, which is expected to impede product adoption.
  • • Biomarker-related security risks
  • Long-duration timeline for the development of biomarkers

Digital Biomarkers Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

32.2%

Base Year Market Size (2024)

USD 3.79 billion

Forecast Year Market Size (2037)

USD 144.84 billion

Regional Scope
  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 3217
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of digital biomarkers is assessed at USD 4.77 billion.

The digital biomarkers market size was valued at USD 3.79 billion in 2024 and is projected to reach USD 144.84 billion by the end of 2037, registering around 32.2% CAGR during the forecast period i.e., between 2025-2037. The increasing number of clinical trials, and the rising burden of cognitive issues and chronic disorders will boost the market growth.

North America industry is poised to dominate 45% revenue share by 2037, propelled by surging cases of Alzheimer disease in the region.

The major players in the market include IMVARIA Inc., nQ Medical, ALTOIDA, ActiGraph, LLC., VivoSense, EVOCAL Health GmbH, Koneksa Health, Cosinuss GmbH, Biofourmis, Lunit Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample